LENSAR, Inc. (LNSR): Capital Expenditures
$83.0K
Year ended 2025-12-31
$35.0K
Trailing 12 months to 2026-06-30
-10.3%
3-year compound annual growth
-25.7%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $83.0K | -46.8% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $156.0K | -33.9% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $236.0K | +105.2% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | $115.0K | -67.5% | 2024-03-04, From 2022-01-01 |
| 2021-12-31 | $354.0K | -3.3% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $366.0K | -5.9% | 2022-03-03, From 2020-01-01 |
| 2019-12-31 | $389.0K | n/a | 2021-03-12, From 2019-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | 2025-12-31 | $83.0K | -46.8% |
| CVRx, Inc. (CVRX) | 2025-12-31 | $580.0K | -57.4% |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | 2025-12-31 | $15.6K | -88.3% |
| Apyx Medical Corp (APYX) | 2025-12-31 | $1.11M | +54.3% |
| Carlsmed, Inc. (CARL) | 2025-12-31 | $642.0K | +256.7% |
| AVITA Medical, Inc. (RCEL) | 2025-12-31 | $1.00M | -89.0% |
| Shoulder Innovations, Inc. (SI) | 2025-12-31 | $7.41M | +84.5% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $918.0K | +166.1% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $224.0K | -41.8% |
Compare LNSR, CVRX, MHUAF, APYX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗